Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other symptoms may include fever, weakness, palpitations, and shortness of breath. Occasionally onset of symptoms is gradual.

Scope of the Report:

This report studies the Pericarditis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pericarditis market by product type and applications/end industries.

Treatment in most cases is with NSAIDs and possibly colchicine. Steroids may be used if those are not appropriate. Typically symptoms improve in a few days to weeks but can occasionally last months. Complications can include cardiac tamponade, myocarditis, and constrictive pericarditis. It is a less common cause of chest pain. About 3 per 10,000 people are affected per year. Those most commonly affected are males between the ages of 20 and 50. Up to 30% of those affected have more than one episode.

The global Pericarditis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pericarditis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Pfizer

Astrazeneca

Bayer

Reckitt Benckiser

Perkinelmer

Fujifilm

Merck Sharp & Dohme

Allergan

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Acute Pericarditis

Chronic Pericarditis

Recurrent Pericarditis

Market Segment by Applications, can be divided into

Hospitals & Clinics

Medical Institutes

Research Organization

Table of Contents

1 Pericarditis Market Overview

1.1 Product Overview and Scope of Pericarditis

1.2 Classification of Pericarditis by Types

1.2.1 Global Pericarditis Revenue Comparison by Types (2017-2023)

1.2.2 Global Pericarditis Revenue Market Share by Types in 2017

1.2.3 Acute Pericarditis

1.2.4 Chronic Pericarditis

1.2.5 Recurrent Pericarditis

1.3 Global Pericarditis Market by Application

1.3.1 Global Pericarditis Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals & Clinics

1.3.3 Medical Institutes

1.3.4 Research Organization

1.4 Global Pericarditis Market by Regions

1.4.1 Global Pericarditis Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Pericarditis Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Pericarditis Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pericarditis Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Pericarditis Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pericarditis Status and Prospect (2013-2023)

1.5 Global Market Size of Pericarditis (2013-2023)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Pericarditis Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.2 Astrazeneca

2.2.1 Business Overview

2.2.2 Pericarditis Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Astrazeneca Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bayer

2.3.1 Business Overview

2.3.2 Pericarditis Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bayer Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.4 Reckitt Benckiser

2.4.1 Business Overview

2.4.2 Pericarditis Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Reckitt Benckiser Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.5 Perkinelmer

2.5.1 Business Overview

2.5.2 Pericarditis Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Perkinelmer Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.6 Fujifilm

2.6.1 Business Overview

2.6.2 Pericarditis Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Fujifilm Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck Sharp & Dohme

2.7.1 Business Overview

2.7.2 Pericarditis Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Sharp & Dohme Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

2.8 Allergan

2.8.1 Business Overview

2.8.2 Pericarditis Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Allergan Pericarditis Revenue, Gross Margin and Market Share (2016-2017)

3 Global Pericarditis Market Competition, by Players

3.1 Global Pericarditis Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Pericarditis Players Market Share

3.2.2 Top 10 Pericarditis Players Market Share

3.3 Market Competition Trend

4 Global Pericarditis Market Size by Regions

4.1 Global Pericarditis Revenue and Market Share by Regions

4.2 North America Pericarditis Revenue and Growth Rate (2013-2018)

4.3 Europe Pericarditis Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Pericarditis Revenue and Growth Rate (2013-2018)

4.5 South America Pericarditis Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Pericarditis Revenue and Growth Rate (2013-2018)

5 North America Pericarditis Revenue by Countries

5.1 North America Pericarditis Revenue by Countries (2013-2018)

5.2 USA Pericarditis Revenue and Growth Rate (2013-2018)

5.3 Canada Pericarditis Revenue and Growth Rate (2013-2018)

5.4 Mexico Pericarditis Revenue and Growth Rate (2013-2018)

6 Europe Pericarditis Revenue by Countries

6.1 Europe Pericarditis Revenue by Countries (2013-2018)

6.2 Germany Pericarditis Revenue and Growth Rate (2013-2018)

6.3 UK Pericarditis Revenue and Growth Rate (2013-2018)

6.4 France Pericarditis Revenue and Growth Rate (2013-2018)

6.5 Russia Pericarditis Revenue and Growth Rate (2013-2018)

6.6 Italy Pericarditis Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Pericarditis Revenue by Countries

7.1 Asia-Pacific Pericarditis Revenue by Countries (2013-2018)

7.2 China Pericarditis Revenue and Growth Rate (2013-2018)

7.3 Japan Pericarditis Revenue and Growth Rate (2013-2018)

7.4 Korea Pericarditis Revenue and Growth Rate (2013-2018)

7.5 India Pericarditis Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Pericarditis Revenue and Growth Rate (2013-2018)

8 South America Pericarditis Revenue by Countries

8.1 South America Pericarditis Revenue by Countries (2013-2018)

8.2 Brazil Pericarditis Revenue and Growth Rate (2013-2018)

8.3 Argentina Pericarditis Revenue and Growth Rate (2013-2018)

8.4 Colombia Pericarditis Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Pericarditis by Countries

9.1 Middle East and Africa Pericarditis Revenue by Countries (2013-2018)

9.2 Saudi Arabia Pericarditis Revenue and Growth Rate (2013-2018)

9.3 UAE Pericarditis Revenue and Growth Rate (2013-2018)

9.4 Egypt Pericarditis Revenue and Growth Rate (2013-2018)

9.5 Nigeria Pericarditis Revenue and Growth Rate (2013-2018)

9.6 South Africa Pericarditis Revenue and Growth Rate (2013-2018)

10 Global Pericarditis Market Segment by Type

10.1 Global Pericarditis Revenue and Market Share by Type (2013-2018)

10.2 Global Pericarditis Market Forecast by Type (2018-2023)

10.3 Acute Pericarditis Revenue Growth Rate (2013-2023)

10.4 Chronic Pericarditis Revenue Growth Rate (2013-2023)

10.5 Recurrent Pericarditis Revenue Growth Rate (2013-2023)

11 Global Pericarditis Market Segment by Application

11.1 Global Pericarditis Revenue Market Share by Application (2013-2018)

11.2 Pericarditis Market Forecast by Application (2018-2023)

11.3 Hospitals & Clinics Revenue Growth (2013-2018)

11.4 Medical Institutes Revenue Growth (2013-2018)

11.5 Research Organization Revenue Growth (2013-2018)

12 Global Pericarditis Market Size Forecast (2018-2023)

12.1 Global Pericarditis Market Size Forecast (2018-2023)

12.2 Global Pericarditis Market Forecast by Regions (2018-2023)

12.3 North America Pericarditis Revenue Market Forecast (2018-2023)

12.4 Europe Pericarditis Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Pericarditis Revenue Market Forecast (2018-2023)

12.6 South America Pericarditis Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Pericarditis Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Pericarditis Picture

Table Product Specifications of Pericarditis

Table Global Pericarditis and Revenue (Million USD) Market Split by Product Type

Figur